A share price of Milestone Pharmaceuticals Inc [MIST] is currently trading at $1.72, down -0.58%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.
From an analyst’s perspective:
Previously, Rodman & Renshaw started tracking the stock with Buy rating on August 22, 2024, and set its price target to $9. On June 20, 2023, downgrade downgraded it’s rating to Hold and revised its price target to $4 on the stock. Piper Sandler upgraded its rating to a Overweight and increased its price target to $10 on April 22, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $20 as its price target on March 05, 2021. Oppenheimer upgraded its rating to Outperform for this stock on July 29, 2020, but kept the price target unchanged to $18. In a note dated July 24, 2020, Jefferies upgraded an Buy rating on this stock.
Milestone Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.63 and $2.75. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $1.72 at the most recent close of the market. An investor can expect a potential return of 481.4% based on the average MIST price forecast.
Analyzing the MIST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.98 and Total Capital is -1.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -9.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6633 points at the first support level, and at 1.6067 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7833, and for the 2nd resistance point, it is at 1.8467.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Milestone Pharmaceuticals Inc [NASDAQ:MIST] is 4.67. As well, the Quick Ratio is 4.67, while the Cash Ratio is 3.48.
